塞力医疗
(603716)
| 流通市值：32.06亿 | | | 总市值：32.06亿 |
| 流通股本：2.26亿 | | | 总股本：2.26亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 342,777,079.75 | 181,793,715.24 | 1,076,955,608.35 | 857,205,461.5 |
| 营业收入 | 342,777,079.75 | 181,793,715.24 | 1,076,955,608.35 | 857,205,461.5 |
| 二、营业总成本 | 393,612,619.03 | 195,176,452.61 | 1,168,127,783.62 | 925,431,549.78 |
| 营业成本 | 269,994,650.22 | 136,060,409.88 | 836,625,074.62 | 670,914,206.73 |
| 税金及附加 | 1,978,663.59 | 952,273.7 | 6,665,479.73 | 5,081,165 |
| 销售费用 | 30,444,926.86 | 16,994,101.66 | 91,528,753.04 | 71,467,670.26 |
| 管理费用 | 71,325,294.33 | 32,761,541.09 | 160,749,334.24 | 113,181,489.05 |
| 研发费用 | 14,745,301.15 | 6,509,264.3 | 41,775,859.02 | 29,804,720.56 |
| 财务费用 | 5,123,782.88 | 1,898,861.98 | 30,783,282.97 | 34,982,298.18 |
| 其中:利息费用 | 5,101,136.37 | 1,998,457.06 | 33,527,170.19 | 34,656,335.53 |
| 其中:利息收入 | 220,162.84 | 137,383.56 | 3,383,922.74 | 1,237,199.28 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -1,607,910.51 | -187,656.11 | 5,672,676.42 | 7,343,276.69 |
| 资产处置收益 | 37,511.89 | -182,010.54 | 248,367.57 | 880,251.38 |
| 资产减值损失(新) | -1,212,495.67 | -458,284.86 | -53,947,696.8 | -760,803.78 |
| 信用减值损失(新) | -4,942,937.97 | -6,003,661.02 | -10,242,488.96 | -20,713,016.78 |
| 其他收益 | 512,267.07 | 290,828.84 | 2,351,291 | 993,212.15 |
| 四、营业利润 | -58,049,104.47 | -19,923,521.06 | -147,090,026.04 | -80,483,168.62 |
| 加:营业外收入 | 1,553,732.32 | 199,919.7 | 1,182,542.52 | 917,795 |
| 减:营业外支出 | 1,111,515.2 | 23,983.2 | 6,455,604.89 | 793,402.93 |
| 五、利润总额 | -57,606,887.35 | -19,747,584.56 | -152,363,088.41 | -80,358,776.55 |
| 减:所得税费用 | -6,097,141.46 | -2,525,091.22 | 49,079,488.13 | -1,205,573.22 |
| 六、净利润 | -51,509,745.89 | -17,222,493.34 | -201,442,576.54 | -79,153,203.33 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -51,509,745.89 | -17,222,493.34 | -201,442,576.54 | -79,153,203.33 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -47,835,887.9 | -17,519,172.08 | -207,283,948 | -87,244,076.83 |
| 少数股东损益 | -3,673,857.99 | 296,678.74 | 5,841,371.46 | 8,090,873.5 |
| 扣除非经常损益后的净利润 | -47,522,298.65 | -17,708,792.54 | -218,908,801.85 | -102,543,073.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.22 | -0.08 | -1.04 | -0.44 |
| (二)稀释每股收益 | -0.22 | -0.08 | -1.04 | -0.44 |
| 八、其他综合收益 | -247,906.46 | -49,986.53 | -33,894,023.93 | -1,253,927.2 |
| 归属于母公司股东的其他综合收益 | -247,906.46 | -49,986.53 | -33,894,023.93 | -1,253,927.2 |
| 九、综合收益总额 | -51,757,652.35 | -17,272,479.87 | -235,336,600.47 | -80,407,130.53 |
| 归属于母公司股东的综合收益总额 | -48,083,794.36 | -17,569,158.61 | -241,177,971.93 | -88,498,004.03 |
| 归属于少数股东的综合收益总额 | -3,673,857.99 | 296,678.74 | 5,841,371.46 | 8,090,873.5 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |